Dataset: HER2-enriched tumor initiating cell (HTIC) genomic predictor of response following neoadjuvant trastuzumab-based chemotherapy in HER2+ breast cancer
We identified a 17-gene Her2-enriched tumor initiating cell (HTIC) signature in MMTV-Her2/Neu mouse mammary TICs. Here, we show that...
We identified a 17-gene Her2-enriched tumor initiating cell (HTIC) signature in MMTV-Her2/Neu mouse mammary TICs. Here, we show that patients with HTICS+ HER2+:ERα− tumors are more likely to achieve a pathologic complete response to trastuzumab-based neoadjuvant chemotherapy compared with HER2+:ER+ tumors. Neoadjuvant study of 50 HER2-positive breast cancer cases treated with trastuzumab-based chemotherapy pre-operatively. Pre-treatment FNA from primary tumors were obtained and RNA extracted and hybridized to Affymetrix microarrays according to manufacturer protocol. Pathologic response was assessed at the end of neoadjuvant treatment.
- Species:
- human
- Samples:
- 50
- Source:
- E-GEOD-37946
- Updated:
- Dec.12, 2014
- Registered:
- Jun.18, 2014
| Sample | PR | AGE | ER | RESPONSE | STAGE |
|---|---|---|---|---|---|
| GSM930574 | NEG | 49 | NEG | RD | IV |
| GSM930573 | POS | 62 | POS | RD | IIIC |
| GSM930572 | POS | 24 | POS | RD | IIIC |
| GSM93057 | NEG | 54 | NEG | RD | IIIC |
| GSM930570 | POS | 72 | POS | RD | IIB |
| GSM930569 | NEG | 55 | NEG | RD | IIIC |
| GSM930568 | NEG | 61 | NEG | RD | IIIC |
| GSM930567 | POS | 48 | POS | RD | IIIA |
| GSM930566 | NEG | 39 | NEG | RD | IIIC |
| GSM930565 | NEG | 50 | POS | RD | IIIA |
| GSM930564 | NEG | 44 | NEG | RD | IIA |
| GSM930563 | NEG | 51 | NEG | RD | IIB |
| GSM930562 | NEG | 61 | POS | RD | IIB |
| GSM93056 | NEG | 30 | NEG | RD | IIIB |
| GSM930560 | NEG | 52 | NEG | RD | IIIA |
| GSM930559 | NEG | 69 | NEG | RD | IIA |
| GSM930558 | NEG | 56 | POS | RD | IIIC |
| GSM930557 | NEG | 73 | NEG | RD | IIA |
| GSM930556 | POS | 47 | POS | RD | IIIC |
| GSM930555 | NEG | 41 | NEG | RD | IIIC |
| GSM930554 | POS | 49 | POS | RD | IIA |
| GSM930553 | POS | 28 | POS | RD | IIIB |
| GSM930552 | NEG | 57 | NEG | RD | IIA |
| GSM93055 | NEG | 46 | NEG | PCR | IIIC |
| GSM930550 | POS | 30 | POS | PCR | not specified |
| GSM930549 | NEG | 65 | NEG | PCR | IIB |
| GSM930548 | POS | 52 | POS | PCR | IIIB |
| GSM930547 | NEG | 56 | NEG | PCR | IIB |
| GSM93055 | NEG | 46 | NEG | PCR | IIIC |
| GSM930545 | POS | 56 | POS | PCR | IIIA |
| GSM930544 | NEG | 53 | NEG | PCR | IIB |
| GSM930543 | NEG | 62 | NEG | PCR | IIIC |
| GSM930542 | NEG | 55 | NEG | PCR | IIA |
| GSM93054 | NEG | 51 | NEG | PCR | IIIB |
| GSM930540 | POS | 53 | POS | PCR | IIIA |
| GSM930539 | NEG | 41 | NEG | PCR | IIIC |
| GSM930538 | NEG | 50 | POS | PCR | IIIA |
| GSM930537 | NEG | 63 | POS | PCR | IIA |
| GSM930536 | NEG | 38 | POS | PCR | I |
| GSM930535 | NEG | 43 | NEG | PCR | IIIA |
| GSM930534 | NEG | 51 | NEG | PCR | IIIC |
| GSM930533 | NEG | 45 | NEG | PCR | IIIC |
| GSM930532 | POS | 56 | NEG | PCR | IIIA |
| GSM93053 | NEG | 47 | NEG | PCR | IIA |
| GSM930530 | NEG | 36 | NEG | PCR | I |
| GSM930529 | POS | 38 | POS | PCR | IIA |
| GSM930528 | NEG | 30 | NEG | PCR | IIIA |
| GSM930527 | NEG | 52 | NEG | PCR | IIIB |
| GSM930526 | NEG | 34 | NEG | PCR | IIA |
| GSM930525 | NEG | 50 | NEG | PCR | IIA |